Crestor Adverse Events Comparable to Zocor In Statin Safety Report
Executive Summary
AstraZeneca's Crestor falls in the middle of the statin pack in terms of class-related adverse events in actual practice, according to preliminary results of a claims database analysis by the National Lipid Association
You may also be interested in...
FDA Safety Data-mining In Literature To Start With Fluoroquinolones, Lipid Drugs
The agency is seeking a contractor to develop a tool to examine the National Library of Medicine’s MEDLINE database of biomedical articles, with pilot studies that seemed aimed at quantification of already-know risks.
High-Dose Lipitor Is As Safe As Lower Doses, Pfizer Analysis Finds
Treatment-related adverse events for Lipitor 80 mg were similar to those for atorvastatin 10 mg, according to a Pfizer analysis of pooled studies of the cholesterol-lowering drug reported in the January issue of the American Journal of Cardiology
High-Dose Lipitor Is As Safe As Lower Doses, Pfizer Analysis Finds
Treatment-related adverse events for Lipitor 80 mg were similar to those for atorvastatin 10 mg, according to a Pfizer analysis of pooled studies of the cholesterol-lowering drug reported in the January issue of the American Journal of Cardiology